L Elizabeth Elizabeth Budde (Lihua E Budde, L Elizabeth Budde, Lihua Elizabeth Budde, Elizabeth Lihua Budde, Elizabeth Elizabeth Budde)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 49

Top Topics

Hodgkin Lymphoma

Histone Deacetylase

Top Venues

Nature medicine

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Sumanta Kumar Pal, Ben Tran, John B A G Haanen, Michael E Hurwitz, Adrian Sacher, Nizar M Tannir, L Elizabeth Elizabeth Budde, Simon James Harrison, Sebastian Klobuch, Sagar S Patel, Luis Meza, Mary-Lee Dequeant, Anna Ma, Qiuling Ally He, Leah M Williams, Alissa Keegan, Ellen B Gurary, Henia Dar, Sushant Karnik, Changan Guo, Heidi Heath, Rachel R Yuen, Phuong K Morrow, Archana M Agarwal, Samer A Srour
CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell Carcinoma. Cancer discovery 14 (7) (2024)
James K Godfrey, Lei Gao, Geoffrey Shouse, Joo Y Song, Stacy Pak, Brian Lee, Bihong T Chen, Avyakta Kallam, John H Baird, Guido Marcucci, Lucy Ghoda, Stephanie Vauleon, Alexey V Danilov, Alex F Herrera, Larry W Kwak, L Elizabeth Elizabeth Budde
Glofitamab stimulates immune cell infiltration of CNS tumors and induces clinical responses in secondary CNS lymphoma. Blood 144 (4) (2024)
Tamer Othman, John H Baird, Stacy Pak, Matthew G Mei, Alex F Herrera, Joshua Mansour, Geoffrey Shouse, Firoozeh Sahebi, Ricardo Spielberger, Ji-Lian Cai, Leonardo Farol, James Godfrey, Avyakta Kallam, Tycel Phillips, Leslie Popplewell, Tanya Siddiqi, Stephen Forman, L Elizabeth Elizabeth Budde
Real-world experience of axicabtagene ciloleucel, a CD19-directed CAR T-cell therapy, in the second-line treatment of early relapsed or primary refractory large B-cell lymphoma. British journal of haematology (2024)
Tanya Barauskas Dorff, M Suzette Blanchard, Lauren N Adkins, Laura Luebbert, Neena Leggett, Stephanie N Shishido, Alan Macias, Marissa M Del Real, Gaurav Dhapola, Colt Egelston, John P Murad, Reginaldo Cruz Alves Rosa, Jinny Paul, Ammar Chaudhry, Hripsime Martirosyan, Ethan Gerdts, Jamie R Wagner, Tracey Stiller, Dileshni Tilakawardane, Sumanta Kumar Pal, Catalina Martinez, Robert E Reiter, L Elizabeth Elizabeth Budde, Massimo D'Apuzzo, Peter Kuhn, Lior Pachter, Stephen J Forman, Saul J Priceman
PSCA-CAR T cell therapy in metastatic castration-resistant prostate cancer: a phase 1 trial. Nature medicine 30 (6) (2024)
James K Godfrey, Lei Gao, Geoffrey Shouse, Joo Y Song, Stacy Pak, Brian Lee, Bihong T Chen, Avyakta Kallam, John H Baird, Guido Marcucci, Lucy Ghoda, Stephanie Vauleon, Alexey V Danilov, Alex F Herrera, Larry W Kwak, L Elizabeth Elizabeth Budde
Glofitamab stimulates immune cell infiltration of CNS tumors and induces clinical responses in secondary CNS lymphoma. Blood 144 (4) (2024)
James K Godfrey, Lei Gao, Geoffrey Shouse, Joo Y Song, Stacy Pak, Brian Lee, Bihong T Chen, Avyakta Kallam, John H Baird, Guido Marcucci, Lucy Ghoda, Stephanie Vauleon, Alexey V Danilov, Alex F Herrera, Larry W Kwak, L Elizabeth Elizabeth Budde
Glofitamab stimulates immune cell infiltration of CNS tumors and induces clinical responses in secondary CNS lymphoma. Blood 144 (4) (2024)
Tanya Barauskas Dorff, M Suzette Blanchard, Lauren N Adkins, Laura Luebbert, Neena Leggett, Stephanie N Shishido, Alan Macias, Marissa M Del Real, Gaurav Dhapola, Colt Egelston, John P Murad, Reginaldo Cruz Alves Rosa, Jinny Paul, Ammar Chaudhry, Hripsime Martirosyan, Ethan Gerdts, Jamie R Wagner, Tracey Stiller, Dileshni Tilakawardane, Sumanta Kumar Pal, Catalina Martinez, Robert E Reiter, L Elizabeth Elizabeth Budde, Massimo D'Apuzzo, Peter Kuhn, Lior Pachter, Stephen J Forman, Saul J Priceman
PSCA-CAR T cell therapy in metastatic castration-resistant prostate cancer: a phase 1 trial. Nature medicine 30 (6) (2024)
Jennifer L Crombie, Tara Graff, Lorenzo Falchi, Yasmin H Karimi, Rajat Bannerji, Loretta J Nastoupil, Catherine Thieblemont, Renata Ursu, Nancy L Bartlett, Victoria R Nachar, Jonathan Weiss, Jane Osterson, Krish Patel, Joshua D Brody, Jeremy S Abramson, Matthew A Lunning, Nirav N Shah, Ayed Ayed, Manali Kamdar, Benjamin M Parsons, Paolo Caimi, Ian W Flinn, Alex F Herrera, Jeff P Sharman, Marshall McKenna, Philippe Armand, Brad S Kahl, Sonali M Smith, Andrew D Zelenetz, L Elizabeth Elizabeth Budde, Martin Hutchings, Tycel Jovelle Phillips, Michael J Dickinson
Consensus Recommendations on the Management of Toxicity Associated with CD3xCD20 Bispecific Antibody Therapy. Blood (2024)
Tanya Barauskas Dorff, M Suzette Blanchard, Lauren N Adkins, Laura Luebbert, Neena Leggett, Stephanie N Shishido, Alan Macias, Marissa M Del Real, Gaurav Dhapola, Colt Egelston, John P Murad, Reginaldo Cruz Alves Rosa, Jinny Paul, Ammar Chaudhry, Hripsime Martirosyan, Ethan Gerdts, Jamie R Wagner, Tracey Stiller, Dileshni Tilakawardane, Sumanta Kumar Pal, Catalina Martinez, Robert E Reiter, L Elizabeth Elizabeth Budde, Massimo D'Apuzzo, Peter Kuhn, Lior Pachter, Stephen J Forman, Saul J Priceman
PSCA-CAR T cell therapy in metastatic castration-resistant prostate cancer: a phase 1 trial. Nature medicine 30 (6) (2024)
L Elizabeth Elizabeth Budde, Sarit E Assouline, Laurie Helen Sehn, Stephen J Schuster, Sung Soo Yoon, Dok Hyun Yoon, Matthew J Matasar, Francesc Bosch, Won Seog Kim, Loretta J Nastoupil, Ian W Flinn, Mazyar Shadman, Catherine S Diefenbach, Chan Yoon Y Cheah, Connie Y Ma, Huang Huang, Antonia Kwan, Michael C Wei, Shen Yin, Nancy L Bartlett
Durable Responses With Mosunetuzumab in Relapsed/Refractory Indolent and Aggressive B-Cell Non-Hodgkin Lymphomas: Extended Follow-Up of a Phase I/II Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (19) (2024)
L Elizabeth Elizabeth Budde, Sarit E Assouline, Laurie Helen Sehn, Stephen J Schuster, Sung Soo Yoon, Dok Hyun Yoon, Matthew J Matasar, Francesc Bosch, Won Seog Kim, Loretta J Nastoupil, Ian W Flinn, Mazyar Shadman, Catherine S Diefenbach, Chan Yoon Y Cheah, Connie Y Ma, Huang Huang, Antonia Kwan, Michael C Wei, Shen Yin, Nancy L Bartlett
Durable Responses With Mosunetuzumab in Relapsed/Refractory Indolent and Aggressive B-Cell Non-Hodgkin Lymphomas: Extended Follow-Up of a Phase I/II Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (19) (2024)
James K Godfrey, Lei Gao, Geoffrey Shouse, Joo Y Song, Stacy Pak, Brian Lee, Bihong T Chen, Avyakta Kallam, John H Baird, Guido Marcucci, Lucy Y Ghoda, Stephanie Vauleon, Alexey V Danilov, Alex F Herrera, Larry W Kwak, L Elizabeth Elizabeth Budde
Glofitamab stimulates immune cell infiltration of CNS tumors and induces clinical responses in secondary CNS lymphoma. Blood (2024)
James K Godfrey, Lei Gao, Geoffrey Shouse, Joo Y Song, Stacy Pak, Brian Lee, Bihong T Chen, Avyakta Kallam, John H Baird, Guido Marcucci, Lucy Ghoda, Stephanie Vauleon, Alexey V Danilov, Alex F Herrera, Larry W Kwak, L Elizabeth Elizabeth Budde
Glofitamab stimulates immune cell infiltration of CNS tumors and induces clinical responses in secondary CNS lymphoma. Blood 144 (4) (2024)
James K Godfrey, Lei Gao, Geoffrey Shouse, Joo Y Song, Stacy Pak, Brian Lee, Bihong T Chen, Avyakta Kallam, John H Baird, Guido Marcucci, Lucy Y Ghoda, Stephanie Vauleon, Alexey V Danilov, Alex F Herrera, Larry W Kwak, L Elizabeth Elizabeth Budde
Glofitamab stimulates immune cell infiltration of CNS tumors and induces clinical responses in secondary CNS lymphoma. Blood (2024)
Sumanta Kumar Pal, Ben Tran, John B A G Haanen, Michael E Hurwitz, Adrian Sacher, Nizar M Tannir, L Elizabeth Elizabeth Budde, Simon James Harrison, Sebastian Klobuch, Sagar S Patel, Luis Meza, Mary-Lee Dequeant, Anna Ma, Qiuling Ally He, Leah M Williams, Alissa Keegan, Ellen B Gurary, Henia Dar, Sushant Karnik, Changan Guo, Heidi Heath, Rachel R Yuen, Phuong K Morrow, Archana M Agarwal, Samer A Srour
CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell Carcinoma. Cancer discovery 14 (7) (2024)
L Elizabeth Elizabeth Budde, Sarit E Assouline, Laurie Helen Sehn, Stephen J Schuster, Sung Soo Yoon, Dok Hyun Yoon, Matthew J Matasar, Francesc Bosch, Won Seog Kim, Loretta J Nastoupil, Ian W Flinn, Mazyar Shadman, Catherine S Diefenbach, Chan Yoon Y Cheah, Connie Y Ma, Huang Huang, Antonia Kwan, Michael C Wei, Shen Yin, Nancy L Bartlett
Durable Responses With Mosunetuzumab in Relapsed/Refractory Indolent and Aggressive B-Cell Non-Hodgkin Lymphomas: Extended Follow-Up of a Phase I/II Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (19) (2024)
Sumanta Kumar Pal, Ben Tran, John B A G Haanen, Michael E Hurwitz, Adrian Sacher, Nizar M Tannir, L Elizabeth Elizabeth Budde, Simon James Harrison, Sebastian Klobuch, Sagar S Patel, Luis Meza, Mary-Lee Dequeant, Anna Ma, Qiuling Ally He, Leah M Williams, Alissa Keegan, Ellen B Gurary, Henia Dar, Sushant Karnik, Changan Guo, Heidi Heath, Rachel R Yuen, Phuong K Morrow, Archana M Agarwal, Samer A Srour
CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell Carcinoma. Cancer discovery (2024)
Tanya Barauskas Dorff, M Suzette Blanchard, Lauren N Adkins, Laura Luebbert, Neena Leggett, Stephanie N Shishido, Alan Macias, Marissa M Del Real, Gaurav Dhapola, Colt Egelston, John P Murad, Reginaldo Cruz Alves Rosa, Jinny Paul, Ammar Chaudhry, Hripsime Martirosyan, Ethan Gerdts, Jamie R Wagner, Tracey Stiller, Dileshni Tilakawardane, Sumanta Kumar Pal, Catalina Martinez, Robert E Reiter, L Elizabeth Elizabeth Budde, Massimo D'Apuzzo, Peter Kuhn, Lior Pachter, Stephen J Forman, Saul J Priceman
PSCA-CAR T cell therapy in metastatic castration-resistant prostate cancer: a phase 1 trial. Nature medicine 30 (6) (2024)
Tanya Barauskas Dorff, M Suzette Blanchard, Lauren N Adkins, Laura Luebbert, Neena Leggett, Stephanie N Shishido, Alan Macias, Marissa M Del Real, Gaurav Dhapola, Colt Egelston, John P Murad, Reginaldo Cruz Alves Rosa, Jinny Paul, Ammar Chaudhry, Hripsime Martirosyan, Ethan Gerdts, Jamie R Wagner, Tracey Stiller, Dileshni Tilakawardane, Sumanta Kumar Pal, Catalina Martinez, Robert E Reiter, L Elizabeth Elizabeth Budde, Massimo D'Apuzzo, Peter Kuhn, Lior Pachter, Stephen J Forman, Saul J Priceman
PSCA-CAR T cell therapy in metastatic castration-resistant prostate cancer: a phase 1 trial. Nature medicine (2024)
Zhengyuan Dong, L Elizabeth Elizabeth Budde, Elizabeth Oh, Szymon Szymura, Aaron J Anderson, Marissa Del Real, Soung-Chul Cha, Stephen J Forman, Larry W Kwak, Xiuli Wang
Analysis of polyfunctionality for enhanced BAFF-R CAR T-cell therapy for hematologic malignancies. Blood advances 8 (15) (2024)
Sumanta Kumar Pal, Ben Tran, John B A G Haanen, Michael E Hurwitz, Adrian Sacher, Nizar M Tannir, L Elizabeth Elizabeth Budde, Simon James Harrison, Sebastian Klobuch, Sagar S Patel, Luis Meza, Mary-Lee Dequeant, Anna Ma, Qiuling Ally He, Leah M Williams, Alissa Keegan, Ellen B Gurary, Henia Dar, Sushant Karnik, Changan Guo, Heidi Heath, Rachel R Yuen, Phuong K Morrow, Archana M Agarwal, Samer A Srour
CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell Carcinoma. Cancer discovery 14 (7) (2024)
Zhengyuan Dong, L Elizabeth Elizabeth Budde, Elizabeth Oh, Szymon Jakub Szymura, Aaron J Anderson, Marissa Morales Del Real, Soung-Chul Cha, Stephen J Forman, Larry W Kwak, Xiuli Wang
Analysis of Polyfunctionality for Enhanced CAR T-Cell Therapy for Hematologic Malignancies. Blood advances (2024)
L Elizabeth Elizabeth Budde, Sarit E Assouline, Laurie Helen Sehn, Stephen J Schuster, Sung Soo Yoon, Dok Hyun Yoon, Matthew J Matasar, Francesc Bosch, Won Seog Kim, Loretta J Nastoupil, Ian W Flinn, Mazyar Shadman, Catherine S Diefenbach, Chan Yoon Y Cheah, Connie Y Ma, Huang Huang, Antonia Kwan, Michael C Wei, Shen Yin, Nancy L Bartlett
Durable Responses With Mosunetuzumab in Relapsed/Refractory Indolent and Aggressive B-Cell Non-Hodgkin Lymphomas: Extended Follow-Up of a Phase I/II Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Zhengyuan Dong, L Elizabeth Elizabeth Budde, Elizabeth Oh, Szymon Szymura, Aaron J Anderson, Marissa Del Real, Soung-Chul Cha, Stephen J Forman, Larry W Kwak, Xiuli Wang
Analysis of polyfunctionality for enhanced BAFF-R CAR T-cell therapy for hematologic malignancies. Blood advances 8 (15) (2024)
Zhengyuan Dong, L Elizabeth Elizabeth Budde, Elizabeth Oh, Szymon Szymura, Aaron J Anderson, Marissa Del Real, Soung-Chul Cha, Stephen J Forman, Larry W Kwak, Xiuli Wang
Analysis of polyfunctionality for enhanced BAFF-R CAR T-cell therapy for hematologic malignancies. Blood advances 8 (15) (2024)
Jennifer L Crombie, Tara Graff, Lorenzo Falchi, Yasmin H Karimi, Rajat Bannerji, Loretta J Nastoupil, Catherine Thieblemont, Renata Ursu, Nancy L Bartlett, Victoria Nachar, Jonathan Weiss, Jane Osterson, Krish Patel, Joshua D Brody, Jeremy S Abramson, Matthew A Lunning, Nirav N Shah, Ayed Ayed, Manali Kamdar, Benjamin Parsons, Paolo F Caimi, Ian W Flinn, Alex F Herrera, Jeffrey Sharman, Marshall McKenna, Philippe Armand, Brad S Kahl, Sonali M Smith, Andrew D Zelenetz, L Elizabeth Elizabeth Budde, Martin Hutchings, Tycel Jovelle Phillips, Michael J Dickinson
Consensus recommendations on the management of toxicity associated with CD3×CD20 bispecific antibody therapy. Blood 143 (16) (2024)
Zhengyuan Dong, L Elizabeth Elizabeth Budde, Elizabeth Oh, Szymon Szymura, Aaron J Anderson, Marissa Del Real, Soung-Chul Cha, Stephen J Forman, Larry W Kwak, Xiuli Wang
Analysis of polyfunctionality for enhanced BAFF-R CAR T-cell therapy for hematologic malignancies. Blood advances 8 (15) (2024)
Jennifer L Crombie, Tara Graff, Lorenzo Falchi, Yasmin H Karimi, Rajat Bannerji, Loretta J Nastoupil, Catherine Thieblemont, Renata Ursu, Nancy L Bartlett, Victoria R Nachar, Jonathan Weiss, Jane Osterson, Krish Patel, Joshua D Brody, Jeremy S Abramson, Matthew A Lunning, Nirav N Shah, Ayed Ayed, Manali Kamdar, Benjamin M Parsons, Paolo Caimi, Ian W Flinn, Alex F Herrera, Jeff P Sharman, Marshall McKenna, Philippe Armand, Brad S Kahl, Sonali M Smith, Andrew D Zelenetz, L Elizabeth Elizabeth Budde, Martin Hutchings, Tycel Jovelle Phillips, Michael J Dickinson
Consensus Recommendations on the Management of Toxicity Associated with CD3xCD20 Bispecific Antibody Therapy. Blood (2024)
Tamer Othman, John H Baird, Stacy Pak, Matthew G Mei, Alex F Herrera, Joshua Mansour, Geoffrey Shouse, Firoozeh Sahebi, Ricardo Spielberger, Ji-Lian Cai, Leonardo Farol, James Godfrey, Avyakta Kallam, Tycel Phillips, Leslie Popplewell, Tanya Siddiqi, Stephen Forman, L Elizabeth Elizabeth Budde
Real-world experience of axicabtagene ciloleucel, a CD19-directed CAR T-cell therapy, in the second-line treatment of early relapsed or primary refractory large B-cell lymphoma. British journal of haematology 205 (1) (2024)
L Elizabeth Elizabeth Budde, Sarit E Assouline, Laurie Helen Sehn, Stephen J Schuster, Sung Soo Yoon, Dok Hyun Yoon, Matthew J Matasar, Francesc Bosch, Won Seog Kim, Loretta J Nastoupil, Ian W Flinn, Mazyar Shadman, Catherine S Diefenbach, Chan Yoon Y Cheah, Connie Y Ma, Huang Huang, Antonia Kwan, Michael C Wei, Shen Yin, Nancy L Bartlett
Durable Responses With Mosunetuzumab in Relapsed/Refractory Indolent and Aggressive B-Cell Non-Hodgkin Lymphomas: Extended Follow-Up of a Phase I/II Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (19) (2024)
James K Godfrey, Lei Gao, Geoffrey Shouse, Joo Y Song, Stacy Pak, Brian Lee, Bihong T Chen, Avyakta Kallam, John H Baird, Guido Marcucci, Lucy Y Ghoda, Stephanie Vauleon, Alexey V Danilov, Alex F Herrera, Larry W Kwak, L Elizabeth Elizabeth Budde
Glofitamab stimulates immune cell infiltration of CNS tumors and induces clinical responses in secondary CNS lymphoma. Blood (2024)
Zhengyuan Dong, L Elizabeth Elizabeth Budde, Elizabeth Oh, Szymon Szymura, Aaron J Anderson, Marissa Del Real, Soung-Chul Cha, Stephen J Forman, Larry W Kwak, Xiuli Wang
Analysis of polyfunctionality for enhanced BAFF-R CAR T-cell therapy for hematologic malignancies. Blood advances 8 (15) (2024)
L Elizabeth Elizabeth Budde, Adam J Olszewski, Sarit Assouline, Izidore S Lossos, Catherine Diefenbach, Manali Kamdar, Nilanjan Ghosh, Dipenkumar Modi, Waleed Sabry, Seema Naik, Amitkumar Mehta, Shazia K Nakhoda, Stephen D Smith, Kathleen Dorritie, Ting Jia, Song Pham, Ling-Yuh Huw, Jing Jing, Hao Wu, Wahib S Ead, Iris To, Connie Lee Batlevi, Michael C Wei, Julio C Chavez
Mosunetuzumab with polatuzumab vedotin in relapsed or refractory aggressive large B cell lymphoma: a phase 1b/2 trial. Nature medicine (2023)
Alex Chehrazi-Raffle, L Elizabeth Elizabeth Budde, Sumanta Kumar Pal
Boosting CAR T cells with anti-tumor mRNA vaccines. Nature medicine (2023)
Matthew G Mei, Lu Chen, James K Godfrey, Joo Y Song, Colt A Egelston, L Elizabeth Elizabeth Budde, Saro H Armenian, Liana Nikolaenko, Mary Nwangwu, Weihua Guo, Lei Gao, Peter Lee, Robert W Chen, Shari Daniels, Neena Kennedy, Lacolle Peters, Jasmine Zain, Steven T Rosen, Stephen J Forman, Leslie L Popplewell, Larry W Kwak, Alex F Herrera
Pembrolizumab plus vorinostat is highly active in Hodgkin lymphoma, including patients refractory to prior PD-1 blockade. Blood (2023)
Claire Roddie, Lazaros J Lekakis, Maria A V Marzolini, Aravind Ramakrishnan, Yiyun Zhang, Yanqing Hu, Vijay G R Peddareddigari, Nushmia Z Khokhar, Robert W Chen, Silvia Basilico, Meera Raymond, Frederick Arce Vargas, Kevin Duffy, Wolfram Brugger, Maeve O'Reilly, Leigh Wood, David Linch, Karl S Peggs, Carlos Bachier, L Elizabeth Elizabeth Budde, Connie Lee Batlevi, Nancy L Bartlett, David Irvine, Eleni Tholouli, Wendy Osborne, Kirit M Ardeshna, Martin A Pule
Dual targeting of CD19 and CD22 with Bicistronic CAR-T cells in Patients with Relapsed/Refractory Large B Cell Lymphoma. Blood (2023)
Nancy L Bartlett, Sarit Assouline, Pratyush Giri, Stephen J Schuster, Chan Yoon Y Cheah, Matthew J Matasar, Gareth Peter Gregory, Dok-Hyun Yoon, Mazyar Shadman, Keith Fay, Sung Soo Yoon, Carlos Panizo, Ian W Flinn, Anna M Johnston, Francesc Bosch, Laurie H Sehn, Michael C Wei, Shen Yin, Iris To, Chi-Chung Li, Huang Huang, Antonia Kwan, Elicia Penuel, L Elizabeth Elizabeth Budde
Mosunetuzumab monotherapy is active and tolerable in patients with relapsed/refractory diffuse large B-cell lymphoma. Blood advances (2023)
Stephen J Schuster, Ling-Yuh Huw, Christopher R Bolen, Victor Maximov, Andrew G Polson, Katerina Hatzi, Elisabeth A Lasater, Sarit E Assouline, Nancy L Bartlett, L Elizabeth Elizabeth Budde, Matthew J Matasar, Hartmut Koeppen, Emily C Piccione, Deanna Wilson, Michael C Wei, Shen Yin, Elicia Penuel
Loss of CD20 expression as a mechanism of resistance to mosunetuzumab in relapsed/refractory B-cell lymphomas. Blood (2023)
Shin Yeu Ong, Stacy Pak, Matthew G Mei, Yan Wang, Leslie Popplewell, John H Baird, Alex F Herrera, Geoffrey Shouse, Liana Nikolaenko, Jasmine M Zain, James Godfrey, Myo Htut, Ahmed Aribi, Ricardo Spielberger, Joshua Mansour, Stephen J Forman, Joycelynne Palmer, L Elizabeth Elizabeth Budde
Bendamustine lymphodepletion is a well-tolerated alternative to fludarabine and cyclophosphamide lymphodepletion for axicabtagene ciloleucel therapy for aggressive B-cell lymphoma. American journal of hematology (2023)
Michael Rainone, Dat Ngo, John H Baird, L Elizabeth Elizabeth Budde, Myo Htut, Ibrahim Aldoss, Vinod A Pullarkat
Interferon-γ blockade in CART-cell therapy-associated macrophage activation syndrome/hemophagocytic lymphohistiocytosis. Blood advances (2022)
Swetha Kambhampati, Monica Saumoy, Yecheskel Schneider, Stacy Pak, L Elizabeth Elizabeth Budde, Matthew G Mei, Tanya Siddiqi, Leslie L Popplewell, Yi-Ping Wen, Jasmine M Zain, Stephen J Forman, Larry W Kwak, Steven T Rosen, Alexey V Danilov, Alex F Herrera, Nikhil Thiruvengadam
Cost Effectiveness of Polatuzumab Vedotin Combined with Chemoimmunotherapy in Untreated Diffuse Large B-cell Lymphoma. Blood (2022)
Paolo Strati, Morton Coleman, Rebecca Champion, Shuo Ma, Caterina Patti, Moshe Y Levy, Izidore S Lossos, Praveen Ramakrishnan Geethakumari, Selay Lam, Roser Calvo, Kara Higgins, L Elizabeth Elizabeth Budde
A phase 2, multicentre, open-label trial (ACE-LY-003) of acalabrutinib in patients with relapsed or refractory marginal zone lymphoma. British journal of haematology 199 (1) (2022)
Ibrahim Aldoss, Samer K Khaled, Xiuli Wang, Joycelynne Palmer, Yan Wang, Jamie R Wagner, Mary C Clark, Jennifer Simpson, Jinny Paul, Vibhuti Vyas, Sheng-Hsuan Chien, Anthony S Stein, Vinod A Pullarkat, Amandeep Salhotra, Monzr M Al Malki, Sandra H Thomas, L Elizabeth Elizabeth Budde, Guido Marcucci, Christine E Brown, Stephen J Forman
Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T Cell Therapy in Adults with high-risk Relapsed/Refractory ALL. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Swetha Kambhampati, Monica Saumoy, Yecheskel Schneider, Steve Serrao, Pejman Solaimani, L Elizabeth Elizabeth Budde, Matthew G Mei, Leslie L Popplewell, Tanya Siddiqi, Jasmine Zain, Stephen J Forman, Larry W Kwak, Steven T Rosen, Alexey V Danilov, Alex F Herrera, Nikhil R Thiruvengadam
Cost-effectiveness of second-line axicabtagene ciloleucel in relapsed refractory diffuse large B-cell lymphoma. Blood 140 (19) (2022)
L Elizabeth Elizabeth Budde, Sarit E Assouline, Laurie Helen Sehn, Stephen J Schuster, Sung-Soo Yoon, Dok Hyun Yoon, Matthew J Matasar, Francesc Bosch, Won Seog Kim, Loretta J Nastoupil, Ian W Flinn, Mazyar Shadman, Catherine S Diefenbach, Carol O'Hear, Huang Huang, Antonia Kwan, Chi-Chung Li, Emily C Piccione, Michael C Wei, Shen Yin, Nancy L Bartlett
Single-Agent Mosunetuzumab Shows Durable Complete Responses in Patients With Relapsed or Refractory B-Cell Lymphomas: Phase I Dose-Escalation Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (5) (2021)
Craig A Portell, Nolan A Wages, Brad S Kahl, L Elizabeth Elizabeth Budde, Robert W Chen, Jonathon B Cohen, Nikole E Varhegyi, Gina R Petroni, Michael E Williams
Dose Finding Study of Ibrutinib and Venetoclax in Relapsed or Refractory Mantle Cell Lymphoma. Blood advances (2021)
Tanya Siddiqi, Xiuli Wang, M Suzette Blanchard, Jamie R Wagner, Leslie L Popplewell, L Elizabeth Elizabeth Budde, Tracey L Stiller, Mary C Clark, Laura Lim, Vibhuti Vyas, Christine E Brown, Stephen J Forman
CD19-directed CAR T-cell therapy for treatment of primary CNS lymphoma. Blood advances 5 (20) (2021)
Nina Shah, Miguel-Ángel Perales, Cameron J Turtle, Mitchell S Cairo, Andrew J Cowan, Hayder Saeed, L Elizabeth Elizabeth Budde, Alan Tan, Zachary Lee, Kazuharu Kai, Mario Q Marcondes, Jonathan Zalevsky, Mary A Tagliaferri, Krina K Patel
Phase I study protocol: NKTR-255 as monotherapy or combined with daratumumab or rituximab in hematologic malignancies. Future oncology (London, England) 17 (27) (2021)
L Elizabeth Elizabeth Budde, David Wu, Daniel B Martin, Mary Philip, Andrei R Shustov, Stephen D Smith, Ted A Gooley, Tara L Chen, Edward N Libby, Eric Y Chen, Kiarash Kojouri, Alan Langerak, Jennifer E Roden, Oliver W Press, Ajay K Gopal
Bendamustine with rituximab, etoposide and carboplatin (T(R)EC) in relapsed or refractory aggressive lymphoma: a prospective multicentre phase 1/2 clinical trial. British journal of haematology 183 (4) (2018)